Literature DB >> 24029639

Rapid progression of unilateral moyamoya disease in a patient with a family history and an RNF213 risk variant.

Yohei Mineharu1, Yasushi Takagi, Jun C Takahashi, Hirokuni Hashikata, Wanyang Liu, Toshiaki Hitomi, Hatasu Kobayashi, Akio Koizumi, Susumu Miyamoto.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24029639     DOI: 10.1159/000352065

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


× No keyword cloud information.
  18 in total

1.  Rapid contralateral progression of focal cerebral arteriopathy distinguished from RNF213-related moyamoya disease and fibromuscular dysplasia.

Authors:  Yoshio Araki; Yasushi Takagi; Yohei Mineharu; Hatasu Kobayashi; Susumu Miyamoto; Toshihiko Wakabayashi
Journal:  Childs Nerv Syst       Date:  2017-05-11       Impact factor: 1.475

2.  RNF213 rare variants in an ethnically diverse population with Moyamoya disease.

Authors:  Alana C Cecchi; Dongchuan Guo; Zhao Ren; Kelly Flynn; Regie Lyn P Santos-Cortez; Suzanne M Leal; Gao T Wang; Ellen S Regalado; Gary K Steinberg; Jay Shendure; Michael J Bamshad; James C Grotta; Deborah A Nickerson; Hariyadarshi Pannu; Dianna M Milewicz
Journal:  Stroke       Date:  2014-10-02       Impact factor: 7.914

3.  Early-onset stroke with moyamoya-like syndrome and extraneurological signs: a first reported paediatric series.

Authors:  Bruno Law-Ye; Guillaume Saliou; Frédérique Toulgoat; Marc Tardieu; Kumaran Deiva; Catherine Adamsbaum; Béatrice Husson
Journal:  Eur Radiol       Date:  2015-11-28       Impact factor: 5.315

4.  The association between the ring finger protein 213 (RNF213) polymorphisms and moyamoya disease susceptibility: a meta-analysis based on case-control studies.

Authors:  Xun-Sha Sun; Jun Wen; Jiao-Xing Li; Rong Lai; Yu-Fang Wang; Hui-Jiao Liu; Wen-Li Sheng
Journal:  Mol Genet Genomics       Date:  2016-02-05       Impact factor: 3.291

5.  Tobacco habituated and non-habituated subjects exhibit different mutational spectrums in head and neck squamous cell carcinoma.

Authors:  Rakesh M Rawal; Madhvi N Joshi; Poonam Bhargava; Inayat Shaikh; Aanal S Pandit; Riddhi P Patel; Shanaya Patel; Kiran Kothari; Manoj Shah; Akshay Saxena; Snehal B Bagatharia
Journal:  3 Biotech       Date:  2014-12-03       Impact factor: 2.406

6.  Development of moyamoya disease in pregnancy and puerperium: case report.

Authors:  Yosuke Akamatsu; Miki Fujimura; Hiroshi Uenohara; Hiroaki Shimizu; Teiji Tominaga
Journal:  Neurol Med Chir (Tokyo)       Date:  2014-09-29       Impact factor: 1.742

7.  Systematic Validation of RNF213 Coding Variants in Japanese Patients With Moyamoya Disease.

Authors:  Yosuke Moteki; Hideaki Onda; Hidetoshi Kasuya; Taku Yoneyama; Yoshikazu Okada; Kengo Hirota; Maki Mukawa; Tadashi Nariai; Shohei Mitani; Hiroyuki Akagawa
Journal:  J Am Heart Assoc       Date:  2015-05-11       Impact factor: 5.501

8.  Repeated de novo aneurysm formation after anastomotic surgery: Potential risk of genetic variant RNF213 c.14576G>A.

Authors:  Yuta Fukushima; Satoru Miyawaki; Tomohiro Inoue; Seiichiro Shimizu; Gakushi Yoshikawa; Hideaki Imai; Nobuhito Saito; Kazuo Tsutsumi
Journal:  Surg Neurol Int       Date:  2015-03-20

Review 9.  Moyamoya disease and syndromes: from genetics to clinical management.

Authors:  Stéphanie Guey; Elisabeth Tournier-Lasserve; Dominique Hervé; Manoelle Kossorotoff
Journal:  Appl Clin Genet       Date:  2015-02-16

Review 10.  Moyamoya Disease: Treatment and Outcomes.

Authors:  Tackeun Kim; Chang Wan Oh; Jae Seung Bang; Jeong Eun Kim; Won-Sang Cho
Journal:  J Stroke       Date:  2016-01-29       Impact factor: 6.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.